Linvoseltamab

• Target :

  Integrin|||TNF

• Related Pathways :

  Apoptosis|||Cytoskeletal Signaling

• Bioactivity :

  Linvoseltamab, a bispecific antibody, targets both BCMA (TNFRSF17) and CD3 epsilon, demonstrating a favorable safety profile and promising efficacy in relapsed/refractory multiple myeloma (RRMM) [1][2].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2408319-25-3